2026-W46 · Nov 9–Nov 15 · Company · Profile · published
Cigna company profile · health services — Cigna Healthcare & Evernorth · history · financial snapshot · S&P 500 rank #164 · 信諾集團公司業務歷史財務與標普500地位
SNAPSHOT
| Ticker | CI (NYSE) |
| Company | The Cigna Group |
| GICS sector / industry | Health Care (XLV) / Health Care Providers & Services |
| S&P 500 rank (by weight) | #164 · 0.11% (Oct 30, 2026) |
| Sector rank (by market cap) | #23 in Health Care (Oct 30, 2026) |
| Share price (frozen benchmark) | $298.23 (Oct 30, 2026) |
| Headquarters | Bloomfield, Connecticut (900 Cottage Grove Road) |
| Founded | 1982 (merger of Connecticut General and INA Corporation; predecessors 1865 and 1792) |
| CEO | Brian Evanko (President and CEO) |
| Employees | c. 67,700 (2025) |
| Market cap | $78.80B (Oct 30, 2026) |
WHAT IT DOES
The Cigna Group is a global health services company providing insurance and related products through two primary divisions: Cigna Healthcare and Evernorth Health Services. Cigna Healthcare provides health benefits and insurance; Evernorth provides pharmacy benefit management and specialty pharmacy services, greatly expanded by its 2018 merger with Express Scripts, mostly sold to health insurance plans and employers. The group serves more than 178 million customer relationships worldwide and operates in more than 30 countries.
The model is premiums plus pharmacy services: Cigna Healthcare collects premiums and manages medical costs, while Evernorth earns fees and spreads on drug benefits. FY2025 revenue was $274.90B, operating income was $8.15B and net income was $5.96B. FY2024 revenue was $247.12B (PitchBook table: $246.148B) and FY2024 net income was $3.43B.
Cigna Corporation was formed in 1982 through the merger of Connecticut General Life Insurance Company (founded 1865) and INA Corporation (founded 1792); the name combines letters from both predecessor companies. In 2023 the company rebranded from Cigna Corporation to The Cigna Group, with Cigna Healthcare and Evernorth Health Services divisions. David Cordani is executive chair; Brian Evanko is president and CEO. In early 2024 Cigna agreed to sell its Medicare Advantage, Supplemental Benefits, Medicare Part D and CareAllies businesses to Health Care Service Corporation (HCSC) in a transaction valued at about $3.7B, which closed in March 2025.
BUSINESS SEGMENTS — FY2025 NET SALES
| Segment | Revenue | Share | YoY |
|---|---|---|---|
| Evernorth Health Services | — | — | — |
| Cigna Healthcare | — | — | — |
HISTORY
| Year | Milestone |
|---|---|
| 1792 | INA Corporation predecessor founded |
| 1865 | Connecticut General Life Insurance Company founded |
| 1982 | Cigna Corporation formed through the merger of Connecticut General and INA Corporation |
| 2018 | Merger with Express Scripts greatly expands pharmacy benefit management |
| 2023 | Company rebrands from Cigna Corporation to The Cigna Group |
| 2025 | Sale of Medicare Advantage, Supplemental Benefits, Medicare Part D and CareAllies businesses to HCSC closes in March 2025; FY2025 revenue $274.90B |
COMPETITIVE POSITION
FINANCIAL SNAPSHOT — FY2025
| Total revenue | $274.90B |
| Operating income | $8.15B |
| Net income | $5.96B |
| FY2024 revenue (comparative) | $247.12B |
| FY2024 net income (comparative) | $3.43B |
| Total assets | $157.92B (FY2025) |
KEY RISKS
WHY IT MATTERS FOR THE S&P 500
Cigna is the S&P 500's health-services name: at a 0.11% index weight and #23 in Health Care by market cap, it is the index's main exposure to pharmacy benefit management alongside health insurance.
Its medical cost trend and Evernorth growth are a standing read on American health spending — drug and care costs show up here before they show up in national health accounts.
SOURCES & METHODOLOGY
| Market data | Slickcharts S&P 500 by weight (rank, weight, price — Oct 30, 2026 close) |
| Financials | The Cigna Group FY2025 results (fiscal year ended Dec 31, 2025), company profile sources |
| Sector classification | GICS (Health Care Providers & Services) via the List of S&P 500 companies (Wikipedia) |
| Library data | SPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics. SPXSet chart library, monthly bars, compiled from Yahoo public information. |
Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com
FINANCIALS
公司快照
| 代碼 | CI(NYSE) |
| 公司 | The Cigna Group |
| GICS 板塊/行業 | 醫療保健(XLV)/醫療保健供應商與服務 |
| 標普500排名(按權重) | #164 · 0.11%(2026 年 10 月 30 日) |
| 板塊內排名(按市值) | 醫療保健第 #23(2026 年 10 月 30 日) |
| 股價(凍結基準) | $298.23(2026 年 10 月 30 日) |
| 總部 | 美國康涅狄格州布盧姆菲爾德(小屋林蔭路 900 號) |
| 成立 | 1982 年(Connecticut General 與 INA Corporation 合併;前身 1865 年與 1792 年) |
| 行政總裁 | Brian Evanko(總裁兼行政總裁) |
| 員工 | 約 67,700(2025 年) |
| 市值 | $78.80B(2026 年 10 月 30 日) |
業務概覽
信諾集團是一家全球健康服務公司,透過兩個主要部門提供保險及相關產品:信諾醫療保健(Cigna Healthcare)與 Evernorth 健康服務。信諾醫療保健提供健康福利與保險;Evernorth 提供藥房福利管理與專科藥房服務,2018 年與 Express Scripts 合併後大幅擴張,主要售予健康保險計劃與僱主。集團在全球服務逾 1.78 億客戶關係,在 30 多個國家運營。
其模式是保費加藥房服務:信諾醫療保健收取保費並管理醫療成本,Evernorth 則從藥品福利中賺取費用與差價。FY2025 收入為 $274.90B,營業利潤為 $8.15B,淨利潤為 $5.96B。FY2024 收入為 $247.12B(PitchBook 表為 $246.148B),FY2024 淨利潤為 $3.43B。
Cigna Corporation 於 1982 年由 Connecticut General Life Insurance Company(1865 年創立)與 INA Corporation(1792 年創立)合併組成,名稱取自兩家前身公司的字母。2023 年公司由 Cigna Corporation 更名為信諾集團,下設信諾醫療保健與 Evernorth 健康服務部門。David Cordani 為執行董事長,Brian Evanko 為總裁兼行政總裁。2024 年初,信諾同意將其 Medicare Advantage、補充福利、Medicare Part D 與 CareAllies 業務以約 $37 億售予 Health Care Service Corporation(HCSC),交易於 2025 年 3 月完成。
業務板塊 — FY2025
| 板塊 | 收入 | 佔比 | 同比 |
|---|---|---|---|
| Evernorth 健康服務 | — | — | — |
| 信諾醫療保健 | — | — | — |
歷史沿革
| 年份 | 里程碑 |
|---|---|
| 1792 | INA Corporation 前身創立 |
| 1865 | Connecticut General Life Insurance Company 創立 |
| 1982 | Connecticut General 與 INA Corporation 合併,組成 Cigna Corporation |
| 2018 | 與 Express Scripts 合併,大幅擴張藥房福利管理 |
| 2023 | 公司由 Cigna Corporation 更名為信諾集團 |
| 2025 | 2025 年 3 月完成向 HCSC 出售 Medicare Advantage、補充福利、Medicare Part D 與 CareAllies 業務;FY2025 收入 $274.90B |
競爭地位
財務快照 — FY2025
| 總收入 | $274.90B |
| 營業利潤 | $8.15B |
| 淨利潤 | $5.96B |
| FY2024 收入(比較) | $247.12B |
| FY2024 淨利潤(比較) | $3.43B |
| 總資產 | $157.92B(FY2025) |
主要風險
對標普500的重要性
信諾是標普500的健康服務標的:指數權重 0.11%、醫療保健板塊市值第 #23,是指數對藥房福利管理連同健康保險的主要敞口。
其醫療成本趨勢與 Evernorth 增長,是美國健康支出的常設讀數——藥品與護理成本往往先在此反映,再體現於全國健康賬目。
來源與方法
| 市場數據 | Slickcharts 標普500權重榜(排名、權重、價格——2026 年 10 月 30 日收盤) |
| 財務 | 信諾集團 FY2025 業績(財政年度截至 2025 年 12 月 31 日)、公司簡介來源 |
| 板塊分類 | GICS(醫療保健供應商與服務),據 S&P 500 公司清單(Wikipedia) |
| 圖庫數據 | SPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。 SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。 |
來源:Yahoo Finance 月 K(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份) · SPXSet.com
財報
SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。
Entered 2026-10-31 04:34 · updated 2026-11-14 23:08 · rev 6